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Abstract
Millions of incidents of hand, foot and mouth disease occur annually
in China, with EVA71 and CVA16 as two major causative
pathogens. A provincial surveillance system has been implemented
in Guangdong for almost 5 years to analyze the aetiological
spectrum and epidemic changes. An unusual enterovirus type,
CVA6, was identiﬁed as the predominant serotype associated with
an HFMD epidemic from late 2012 to 2013. In contrast to virus
strains isolated before, all CVA6/CHN/2012–2013 strains segre-
gated into one major genetic cluster. This study suggested that one
cluster of circulating CVA6 strain had emerged as a new and major
cause during a continuing HFMD epidemic in Guangdong, China.
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Introduction
Hand, foot and mouth disease (HFMD), is a major public health
problem in China, resulting in millions of clinical cases and
hundreds of deaths each year. Outbreaks of HFMD were
mainly caused by two types of enterovirus A species, enterovirus
A71 (EVA71) and coxsackievirus A16 (CVA16), with differing
ratios [1–3]. Sporadic cases associated with another coxsac-
kievirus, such as CVA4, CVA5, CVA6, CVA10 and CVB2 to
B5, were occasionally reported [4,5].
Guangdong (GD), as the most populous province in China,
has been suffering from a serious HFMD epidemic [6]. The
number of reported cases was up to 330 645 in 2012 and
Guangdong ranked ﬁrst among 31 provinces in China. Due to
the severity of the HFMD epidemic, a provincial web-based
surveillance system has been established since 2008 [6].
Medical institutions at all levels in GD were responsible for
reporting clinical cases and collecting specimens. HFMD cases
were identiﬁed according to the Ministry of Health diagnostic
criteria (http://www.nhfpc.gov.cn/jkj/index.shtml). Centres for
disease control and prevention (CDCs) at the city level run the
real-time PCR (RT-PCR) for detecting the presence of the
common (universal) sequence of enterovirus and the speciﬁc
sequences of EVA71 and CVA16 [6]. Positive results were
reported to GD CDC. In this study, we described the
provincial surveillance results for HFMD from January 2008 to
August 2013. The HFMD aetiological spectrum and the
epidemic changes were analysed to assess the relative
frequency of enterovirus infections and to provide information
for future surveillance studies and vaccine development.
A total of 1 248 700 HFMD cases were reported from
January 2008 to August 2013; 27 961 EV-positive samples
were sent to GD CDC for verifying and further classiﬁcation.
As illustrated in Fig. 1(a), EVA71 and CVA16 have co-circu-
lated as the two most frequent EV types causing repeated
HFMD outbreaks in GD from 2008 to 2012. EVA71, as the
most predominant EV, represented about 40% of EV-positive
samples, except for in 2009. A similar trend was also observed
at a national level [3,7]. Notably, the changing aetiology was
observed in 2013. A large percentage of non-EVA71 and
non-CVA16 EVs was detected during continuing surveillances.
Retrospective EV serotype screening was carried out on
archived EV-positive samples by using CODEHOP PCR [8].
The PCR products (c. 350–400 nt) were sequenced and the
virus serotype was determined according to a previously
described molecular typing method [9]. From the primary
results, CVA6 was the most isolated serotype in the new
HFMD epidemic in GD.
CODEHOP PCR is not always as sensitive as speciﬁc
RT-PCR for detecting certain serotypes of EV [10]. To
improve the detection rate, CVA6-speciﬁc real-time RT-PCR
was performed by using a commercial kit (JC20106, bioPer-
fectus technologies, Jiangsu, China). The speciﬁcity of this kit
was ﬁrstly conﬁrmed in the laboratory. One hundred
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EV-positive samples were randomly selected during each
month from January 2012 to August of 2013 and speciﬁc
RT-PCR for EVA71, CVA16 and CVA6 was performed to
analysis the distribution of each EV. As shown in Fig. 1(b),
EVA71 and CVA16 were detected as the predominant viruses
(>60%) from January to August 2012 and the total reported
HFMD cases attained a peak in May. In contrast, CVA6, a rare
viral pathogen in previous epidemics, was also detected during
July 2012 and replaced EVA71 and CVA16 as the major
HFMD-associated pathogen from September 2012. In addition,
this new outbreak of CVA6 infection may contribute to the
second peak of the HFMD epidemic during September 2012.
This epidemic change became more obvious during 2013. In
total, of 800 enterovirus-positive samples collected from
January to August of 2013, 483 (60.3%) were caused by CVA6,
119 (14.8%) by EVA71, 89 (11.1%) by CVA16, and 109 (14.1%)
by other untyped enteroviruses. The peak detection of CVA6
occurred during June and July, coinciding with the HFMD
summer pandemic. All these ﬁndings suggested that CVA6 was
the major circulating EV and responsible for the continuing
HFMD epidemic in 2013.
Direct sequencing was performed on the full VP1 region of
69 randomly selected CVA6-positive samples (Genbank Acces-
sion Number: KF734951-KF734960 and KF836548-KF836606).
Maximum likelihood (ML) trees were estimated by using the
best-ﬁt Kimura 2-parameter + I model of nucleotide substitu-
tion in Mega 5.0 [11]. A phylogenetic tree drawn on the basis of
55 representative sequences segregated CVA6 strains into six
(a)
(b)
FIG. 1. (a) Enterovirus-assoicated HFMD cases and enterovirus distribution in Guangdong Province, China, from 2008 to August 2013. The
continuous line describes the total number of HFMD cases reported each year in Guangdong; the histogram shows the percentage of EVA71, CVA16
and other untyped enterovirus isolates in EV-positive samples. (b) Monthly distribution of CVA6, EVA71, CVA16 and other untyped enteroviruses in
Guangdong Province, China, from 2012 to August 2013. The continuous line describes the total number of HFMD cases reported each month in
Guangdong; the histogram shows the distribution of EVA71, CVA16, CVA6 and other untyped enterovirus isolates in each month. The high ratio of
CVA6, which began to be detected in September of 2012, is highlighted with a dashed border.
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FIG. 2. Phylogenetic analysis of coxsackievirus A6 partial (915 bp) viral capsid protein 1 nucleotide sequences (nt 2441–3357 according toGdula strain
AY421764), showing the relationships between the recent clinical CVA6 isolates from GenBank. Genbank accession numbers and location as well as
year of virus isolation are included. Scale bar indicates branch distances; solid circles indicate strains sequenced in this study. Only bootstrap values of
over 75% are shown. The virus strains isolated from 2008 to 2011 in China are marked in blue, and strains isolated from 2012 to 2013 in China are
marked in red. CHN, China; ESP, Spain; FIN, Finland; FRA, France; IND, India; JPN, Japan; SH, Shanghai; SD, Shangdong; GD, Guangdong.
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different clusters (Fig. 2). From 2008 to 2011, the CVA6 strains
isolated from GD as well as other regions of China dispersed
into two different sub-clusters (cluster A and cluster D).
Intriguingly, almost all of the CVA6 strains isolated during the
2012 and 2013 HFMD epidemic in GD and Shanghai (SH) were
segregated into one major genetic cluster A (Fig. 2), and
displayed a close genetic relationship with the 2009/2010
Taiwan strains, 2010 French strains and 2011 Japanese strains
associated with HFMD outbreaks [12–14].
CVA6 infections have seldom been detected and occasion-
ally found in minor outbreaks in Spain [15], Finland [10],
France [13], Singapore [16], Japan [14] and Thailand [17]. In
mainland China, CVA6 was detected as a sole pathogen in 2.5%
of HFMD cases from 2009 to 2011 [5]. Therefore, CVA6
played only a minor role in past HFMD epidemics in China, and
national surveillance and vaccine development was mainly
focused on EVA71 and CVA16.
Our data identiﬁed that CVA6 replaced EVA71 and CVA16
as the most common causative agent of HFMD in GD from
September 2012 to August 2013. In addition, phylogenetic
analysis indicated that almost all sequenced CVA6 strains from
GD and SH during the 2012 and 2013 epidemic shared an
isolated cluster, suggesting that CVA6 strains in this cluster
became the major circulating virus strains in the new HFMD
epidemic in China.
This study provides strong evidence that the previously
infrequently detected CVA6 is becoming the predominant
HFMD pathogen, thus highlighting the necessity of compre-
hensive surveillance of its circulation in HFMD epidemics in
China as well as the rest of the Asia-Paciﬁc region. Moreover,
the changes in the aetiological spectrum during continuing
HFMD epidemics should be highly considered for future
vaccine strategies and clinical management.
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